Is ORKA (Oruka Therapeutics, Inc.) Halal or Haram?

Based on our AAOIFI-standard shariah screening, ORKA is Halal and considered permissible for Muslim investors. It passed all 4 of 4 compliance screens including business activity review, debt-to-market-cap ratio (0.06% vs ≤33% threshold), interest income ratio (0.00% vs ≤5% threshold), and cash & securities ratio (10.81% vs ≤33% threshold).

Oruka Therapeutics, Inc. is a California-based biotechnology company focused on developing novel monoclonal antibody therapeutics. The company primarily targets psoriasis and other inflammation and immunology indications, advancing its clinical pipeline which currently features ORKA-001 and ORKA-002. For Muslim investors, Oruka Therapeutics represents a fully Halal investment opportunity in the healthcare sector. The stock successfully passed all four AAOIFI shariah screens, meaning its core operations and financial structures align strictly with Islamic finance principles. From a financial perspective, the company boasts an incredibly strong compliance profile, particularly regarding its debt levels. With a debt-to-market cap ratio of just 0.1% and absolutely zero interest income, the company carries minimal riba-related risk. Its cash reserves of 10.8% are also well within permissible limits. Since biotechnology companies often require significant capital for clinical trials, investors should monitor future funding rounds to ensure new debt is not taken on. However, its current financial structure makes it a highly attractive, compliant option for biotech exposure. Oruka Therapeutics, Inc. operates in the Healthcare sector under the Biotechnology industry and is headquartered in Menlo Park, MA, US. The company is led by CEO Lawrence Otto Klein and employs approximately 28 people.

ORKA was screened using AAOIFI-based shariah compliance criteria. Four tests are applied: (1) Business Activity — the company's core business must not derive primary income from haram (prohibited) activities such as alcohol, gambling, tobacco, or interest-based finance. (2) Debt-to-Market-Cap — total debt must not exceed 33% of market capitalization. (3) Interest Income — interest income must not exceed 5% of total revenue. (4) Cash & Securities — cash and interest-bearing securities must not exceed 33% of market cap. ORKA passed 4 of these 4 screens.

Although ORKA passes all shariah screens, it does earn $16.6M in interest income (0.00% of revenue). Many scholars recommend purifying this portion by donating the equivalent percentage of any dividends received to charity. For example, if you receive $100 in dividends, you would donate approximately $0.00 to purify the income.

ORKA was last screened on 2026-04-27. Shariah compliance status can change as companies report new financial data, acquire new businesses, or shift revenue streams. We recommend checking back periodically for the most up-to-date screening results.